Shin Nippon Biomedical Laboratories Ltd
Shin Nippon Biomedical Laboratories's Climate Target Data Preview
As of 2024, Shin Nippon Biomedical Laboratories has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 absolute reduction target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Shin Nippon Biomedical Laboratories's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy/Paste is a PRO feature.  a | 2030 |
Verified Sources Behind Shin Nippon Biomedical Laboratories’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Shin Nippon Biomedical Laboratories’s data sources below and access millions more through our Disclosure Search.
Insights into Shin Nippon Biomedical Laboratories's Greenhouse Gas Emissions Pathways
As of 2024, Shin Nippon Biomedical Laboratories has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a
Does Shin Nippon Biomedical Laboratories have a target to reduce the emissions from its operations?
As of 2024, Shin Nippon Biomedical Laboratories has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Shin Nippon Biomedical Laboratories's most ambitious operational target is to reduce these emissions by 45% by 2030, compared to a baseline of 3,176 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.a
Instead of reducing operational emissions, Shin Nippon Biomedical Laboratories has increased them, with 2023 levels exceeding those of the 2020 baseline, placing the company well behind its reduction target.a